RSL Revolutionary Labs

What RSL Revolutionary Labs does

RSL Revolutionary Labs Ltd is a Cyprus-based biotech company founded in 2018 by Dr. Marianna Prokopi-Demetriades and Dr. Anna Christofini, operating out of the ASBIS Hi-Tech Cluster in Limassol. The company develops and commercializes the εὖSKIN® dermaceutical product line — formulations combining natural bioactive extracts with molecularly engineered medical-grade biomaterials designed for sensitive, compromised, and oncology-affected skin. Its flagship technology is the proprietary CollX3 triple-helix atelocollagen complex with three distinct molecular weight ranges, developed with Promed Bioscience through the RIF-funded mediSKIN project and incorporated into the εὖSKIN® Advanced product.

The company's product portfolio includes seven commercial SKUs (Intensive Cream, Recovery Oil, Soothing Body Lotion, Intensive Gel, Nail Repair Oil, Lip Care, and εὖSKIN® Advanced) plus bundled offerings, all positioned for oncology patients experiencing dermatological side effects from chemotherapy, radiotherapy, hormone therapy, and immunotherapy, as well as individuals with sensitive skin and dermatology patients (e.g., those on isotretinoin). Clinical validation is anchored by multi-center trial NCT05588973 in Cyprus and Greece and a partnership with the German Oncology Centre. The company holds ISO 22716, ISO 9001, and ISO 13485 certifications from TUV Austria Hellas and a CPNP notification in Europe.

RSL's business model is hybrid direct-to-consumer and B2B2C distribution: products sell through the company's own e-commerce shop, Cyprus pharmacy networks, and regional distribution partners — Smedo in Greece (signed 2024) and Eshe in Africa (signed September 2025). The company is privately held with disclosed capital of approximately €1.2 million from a €700,000 ASBIS corporate investment (November 2022) and a €498,505 RIF grant for the mediSKIN project. R&D pipeline extends into microRNA-loaded extracellular vesicle therapies through the MiRACULOUS consortium, positioning for longer-term expansion into regenerative medicine.

Name

RSL Revolutionary Labs

Legal name

RSL Revolutionary Labs Ltd

Website

https://rsl-labs.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

RSL Revolutionary Labs is a Cyprus-based biotech company that develops and sells the εὖSKIN® dermaceutical skincare line, formulated for oncology patients and individuals with sensitive or compromised skin, combining natural bioactive extracts with proprietary atelocollagen biomaterials.

Ownership category

akta.pro rank

Product category

Dermaceutical Skincare

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

akta.pro secondary industries

Sensitive Skin & Barrier Repair (CRABAAAG), Professional/Backbar Skincare (Esthetician & Spa Use) (CRABAAAK), Professional Skincare & Facial Treatments (CRABALAF)

Keywords

• Dermaceutical skincare
• Oncology skincare products
• Atelocollagen biomaterials
• Sensitive skin formulations
• Dermato-oncology cosmetics

Headquarters

HQ city

Limassol

HQ country

Cyprus

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Product Sales - Direct to Consumer: RSL sells εὖSKIN dermaceutical products directly to consumers through their e-commerce website. Products include Intensive Cream, Recovery Oil, Soothing Body Lotion, Intensive Gel, Nail Repair Oil, and Lip Care.
2. Wholesale & Distribution: Products distributed through pharmacy networks in Cyprus and international distribution partners in Greece (Smedo) and Africa (Eshe).
3. Investment Capital: Received €700K investment from ASBIS Enterprises Plc for production capacity expansion and international growth.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels9 records

Core offering

RSL Revolutionary Labs develops, manufactures, and sells the εὖSKIN® dermaceutical skincare line — a portfolio of creams, oils, lotions, gels, nail and lip care products formulated for sensitive, compromised, and oncology-affected skin. Products are built around the proprietary CollX3 triple-helix atelocollagen complex and over 15 natural bioactive ingredients, manufactured under ISO 22716/ISO 9001/ISO 13485 certifications in Limassol, Cyprus, and sold direct-to-consumer via e-commerce, Cyprus pharmacies, and distribution partners in Greece and Africa.

Product overview

RSL Revolutionary Labs operates as a biotech company offering the εὖSKIN® dermaceutical product line - a unified portfolio of skincare products specifically formulated for sensitive, compromised, and oncology-affected skin. The product range includes Intensive Cream, Recovery Oil, Soothing Body Lotion, Intensive Gel, Nail Repair Oil, Lip Care, and the advanced εὖSKIN® Advanced formulation featuring the proprietary CollX3 atelocollagen complex. All products are developed in collaboration with scientists, dermatologists, and oncology specialists, incorporating natural ingredients and medical-grade biomaterials validated through clinical research. The company also offers bundled products like the εὖSKIN® Duo Pack for targeted care regimens.

Differentiator

Problem solved

Functional benefit

Brands

• εὖSKIN Advanced: Uniquely designed skincare product that harnesses the power of the innovative atelocollagen complex CollX3, formulated for prevention and recovery of skin damage caused by radiotherapy, chemotherapy, or oncological treatments.
• mediSKIN

Products and services

• εὖSKIN® Intensive Cream Gentle, deeply hydrating cream with Aloe Vera Extract, Shea Butter, and Chamomile Extract, formulated to restore moisture, comfort sensitive skin, reduce visible redness, and support the skin's natural barrier for oncology patients and individuals with sensitive or compromised skin.
• εὖSKIN® Recovery Oil Bioactive oil designed to restore and rejuvenate tired, stressed skin, formulated with compounds that nourish and protect the skin from environmental stressors; intended for users with sensitive, stressed, or oncology-affected skin.
• εὖSKIN® Soothing Body Lotion Gentle body lotion with Balsam oil that calms and moisturizes sensitive skin, helping users feel refreshed and supporting comfort for oncology patients and sensitive-skin consumers.
• εὖSKIN® Intensive Gel Skincare gel containing Aloe Vera with moisturizing properties, formulated for sensitive and compromised skin in the oncology care context.
• εὖSKIN® Nail Repair Oil Conditioning nail oil with hydrating and protective ingredients developed to care for fragile, brittle, or damaged nails, including nails affected by oncological treatments.
• εὖSKIN® Lip Care Mild lip treatment that fuses rejuvenating and moisturizing constituents (Sweet Orange Peel Oil, Calendula, Shea Butter) to soothe dryness and cracks in the lips, suitable for chemotherapy patients and users of drying therapies such as isotretinoin.
• εὖSKIN® Advanced Premium SKU in the εὖSKIN® line that harnesses the proprietary CollX3 triple-helix atelocollagen complex, formulated to support prevention and recovery of skin damage caused by radiotherapy, chemotherapy, and other oncological treatments.
• εὖSKIN® Duo Pack Limited-edition gift set bundling εὖSKIN® SKUs designed to soothe and hydrate stressed skin, offered as part of awareness campaigns such as Pink October in collaboration with Europa Donna Cyprus.

Quantifiable outcome

• 30% of chemotherapy patients develop dermatological toxicities - highlighting the significant unmet need RSL addresses
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered regional, minor and core.

• EsheregionalChannel Partner/ Reseller/ Distributor · 12 September 2025Distribution partnership for Africa market. Eshe will distribute εὖSKIN products in African markets, expanding RSL's geographic reach.
• Europa Donna CyprusminorOthers · 21 October 2024Charity partnership for Pink October breast cancer awareness campaign. Collaboration on promoting employee wellness and championing breast cancer awareness cause.
• Aroma HubminorOthers · 1 July 2024Partnership with Aroma Hub, likely involving product distribution or retail presence.
• SmedoregionalChannel Partner/ Reseller/ DistributorStrategic distribution partnership for εὖSKIN product line in Greece. Smedo is a biomedical technology company providing flexible import services and healthcare products through smedo.gr e-shop. Products distributed include dermaceutical solutions for oncology patients.
• Promed BiosciencecoreStrategic or Co-development PartnerR&D partner in mediSKIN project developing novel medical-grade atelocollagen (CollX3) for oncology skincare formulations. Promed leads the development of high-purity collagen biomaterials for regenerative medicine. Also partner in MiRACULOUS project.
• Theramir LtdcoreStrategic or Co-development PartnerR&D partner with expertise in pharmaceutical preclinical testing and EV delivery systems. Responsible for in vitro efficacy and safety testing using 3D engineered skin models. Also leads MiRACULOUS project and hosts EVmiR platform.
• Cyprus University of TechnologycoreStrategic or Co-development PartnerAcademic partner conducting rigorous characterization of novel biomaterials using state-of-the-art techniques and in-house developed analysis methods. Contributes clinical trial assessment of patient quality of life.
• German Oncology CentrecoreStrategic or Co-development PartnerClinical partner organizing first Cyprus-based clinical trial to assess effect of mediSKIN formulas on patient quality of life. Presents preliminary clinical results and designs clinical trial protocols.
• Vet Ex Machina LtdcoreStrategic or Co-development PartnerPartner in MiRACULOUS project conducting advanced preclinical and veterinary clinical trials including in vivo and ex vivo testing, leveraging state-of-the-art facilities and expertise in tissue engineering, medical devices, and cell-based therapies.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Avène (Pierre Fabre Dermatologie): Pierre Fabre's dermocosmetics brand built around sensitive and compromised skin, including oncology-support ranges. Comparable positioning to RSL's sensitive-skin and oncology-affected-skin product narrative.
• La Roche-Posay: L'Oréal-owned dermocosmetics brand focused on sensitive and pathology-adjacent skin (e.g., post-treatment skincare). Directly comparable category to RSL's εὖSKIN oncology-sensitive positioning, though La Roche-Posay operates at vastly larger scale and broader scope.
• Bioderma (NAOS): NAOS-owned dermocosmetics brand with sensitive-skin and dermatology-adjacent lines, distributed through pharmacies in Europe. Comparable channel mix (pharmacy-led) and sensitive-skin positioning.
• SkinCeuticals (L'Oréal): L'Oréal's science-led skincare brand often recommended by dermatologists and plastic surgeons. Comparable science-positioned skincare, though with a stronger aesthetics rather than oncology-support focus.
• Coloplast: Global medical device and wound/skin care company serving post-surgical and chronic conditions. Comparable as a player addressing wound healing and skin compromise, relevant to RSL's MiRACULOUS pipeline direction.
• Eucerin (Beiersdorf): Beiersdorf's medical skincare brand with oncology-support and barrier-repair ranges. Comparable as a dermocosmetics incumbent serving sensitive and treatment-compromised skin.

Direct peers

• SVR Laboratoires: French dermocosmetics laboratory offering sensitive-skin and pathology-adjacent formulations sold through pharmacies. Comparable as a science-positioned dermocosmetics peer targeting compromised skin.
• Ducray (Pierre Fabre): Pierre Fabre dermatology brand covering sensitive skin, oncology-support, and skin reactions. Direct comparable as a dermocosmetics peer with oncology-affected-skin SKUs.
• ISDIN: Spanish dermocosmetics company with explicit oncology-support skincare lines and strong European pharmacy presence. Most directly comparable peer to RSL in dermato-oncology skincare and pharmacy channel strategy.

Emerging players

• Mölnlycke Health Care: Specializes in wound care and post-treatment skin management, including oncology wound-care adjacencies. Comparable as a company operating at the intersection of wound healing and oncology patient skin care.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@rslrevolutionarylabs471
• Facebookfacebook.com/euskinproducts
• LinkedInlinkedin.com/company/rsl-revolutionary-labs-ltd
• Instagraminstagram.com/euskinproducts

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RSL Revolutionary Labs